Wiersholm has assisted GlucoSet with a private placement

Wiersholm has assisted GlucoSet with a capital raising that enables the company to fully accelerate its operations.
Our team has been led by Svein-Helge Hanken and Erik Ellekjær Kjesbu.
GlucoSet is set to deliver instruments for continuous monitoring of blood sugar at the intensive care units in hospitals. With the Swiss Diabetes Venture Fund on the team and investments from the EIC Fund and EIC Accelerator, the company is aiming for a product launch in 2026. The private placement is mentioned in the Finansavisen on November 24, 2023 (in Norwegian).
Contact people
Published:
27.11.2023